Navigation Links
Carrington Settles Lawsuit, Sets Sights On Future
Date:2/1/2008

no needles, no preservatives, no cold storage and can be shipped anywhere free of the restrictive cold chain distribution systems required for traditional vaccines. As a nasal powder, it's patient-friendly and doesn't require administration by a medical professional. No painful injection could mean greater public acceptance and thus, public protection on a broader scale against specific diseases."

"At the corporate level, we are analyzing our business models and exploring strategies to move our business forward. We've incurred financial losses over recent years, due in part to Carrington's corporate funding of DelSite's initiatives and programs, and due in part to operational losses. We are now evaluating our business segments and growth opportunities with fresh perspectives. To that end, we just announced we have retained the services of an investment advisor to help us understand how we can capitalize on our considerable technologies and assets in a long-range business plan for the ultimate benefit of our shareholders and supporters. Improving shareholder value remains our highest priority."

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally- occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's DelSite Biotechnologies subsidiary is developing its proprietary GelSite(R) technology designed to provide controlled release of peptide and protein-based drugs. Carrington's technology is protected by more than 130 patents in 26 countries. Select products carry the CE mark,
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. Carrington Reports Second Quarter 2007 Results
3. Carrington Completes $8 Million Financing
4. Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
7. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
8. Carrington Reports on ISO 9001:2000 Inspection
9. Carrington Reports Third Quarter 2007 Results
10. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
11. Discover Testing Settles the Drinking Water Debate: Tap vs. Bottled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Vital Imaging ™ has ... California, San Diego for a joint study which aims ... (Magnetic Resonance Imaging) with that of a supine Dynawell ... pursuit of improved healthcare by combining cutting edge technology ... extremely valuable tool for evaluating pathological changes in the ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
(Date:5/21/2013)... MN (PRWEB) May 21, 2013 The ... show display solution for sales and marketing teams looking for ... describes the kit as “everything you’ll need to put ... Fabric Display Kit comes with a number of displays and ... trade booth 20 feet by 20 feet in size. These ...
(Date:5/20/2013)... , Collaboration with the ... in treatment of mastitis , ... to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate ... Service (ARS) to develop and trial products targeting the ...
Breaking Biology Technology:Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2
... by 45.7%, Profit Attributable to Shareholders ... 14 /Xinhua-PRNewswire/ -- Fufeng Group Limited,("Fufeng" or "the ... corn-based biochemical products in China, today announces,its interim ... 2008., During the period under review, driven ...
... Aug. 14 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... the,discovery, development and commercialization of novel drugs in ... today,announced its financial results for the second quarter ... ), The net loss for the three ...
... Derma Sciences, Inc.,(OTC Bulletin Board: DSCI), a provider ... second quarter and first six months ended,June 30, 2008. ... and,distribution capacity provided by the Company,s new First Aid ... flagship product, MEDIHONEY(R). For,the second quarter in 2008, the ...
Cached Biology Technology:Fufeng Announces 2008 Interim Results With Strong Sign of Recovery 2Fufeng Announces 2008 Interim Results With Strong Sign of Recovery 3Advanced Life Sciences Announces Second Quarter 2008 Financial Results 2Advanced Life Sciences Announces Second Quarter 2008 Financial Results 3Advanced Life Sciences Announces Second Quarter 2008 Financial Results 4Advanced Life Sciences Announces Second Quarter 2008 Financial Results 5Advanced Life Sciences Announces Second Quarter 2008 Financial Results 6Advanced Life Sciences Announces Second Quarter 2008 Financial Results 7Advanced Life Sciences Announces Second Quarter 2008 Financial Results 8Advanced Life Sciences Announces Second Quarter 2008 Financial Results 9Advanced Life Sciences Announces Second Quarter 2008 Financial Results 10Derma Sciences Reports Second Quarter 2008 Results 2Derma Sciences Reports Second Quarter 2008 Results 3Derma Sciences Reports Second Quarter 2008 Results 4Derma Sciences Reports Second Quarter 2008 Results 5
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
(Date:5/17/2013)... residents of all ages will celebrate the science ... on our daily lives during the inaugural Atlanta ... and educators from local museums, corporations, K-12 schools ... 40 different events for children and adults at ... http://atlantasciencefestival.org . , The annual Atlanta Science ...
(Date:5/17/2013)... Efficient and Sustainable Global Logistics Operations) is aiming to ... efficiency of intermodal loading systems and the boosting of ... European organisations with experience in the logistics sector and ... 17,000,000 and a duration of three and a half ... the semantic components and ontologies shared by the users, ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2New logistics services that will cut energy consumption and CO2 emissions 2
... New research suggests a higher-protein, lower-carbohydrate energy-restricted diet has ... fat and increasing lean muscle, particularly when the proteins ... the September issue of the Journal of Nutrition, ... otherwise healthy, premenopausal women. Each consumed either low, ...
... Lithuania, Aug. 29, 2011 Neurotechnology ... technologies, today announced the availability of SentiSight 3.0 ... recognition. This latest version adds shape-based recognition and offers ... SentiSight 2.1. It also includes enhanced tracking of fast ...
... which can stop the formation of long protein strands, ... kidney dialysis patients has been identified by researchers at ... to new methods to identify drugs to prevent, treat ... amyloid fibrils play a part, including Alzheimer,s, Parkinson,s and ...
Cached Biology News:Foods rich in protein, dairy products help dieters preserve muscle and lose belly fat: study 2SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 2SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 3SentiSight 3.0 Universal Object Recognition Technology Available Now From Neurotechnology 4Research offers new way to target shape-shifting proteins 2
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
WTAP Antibody...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
...
Biology Products: